© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
© 2020 MJH Life Sciences™ and Cancer Network. All rights reserved.
June 15, 2017
In this interview we discuss the role of checkpoint inhibitors in advanced lung cancer and treatment strategies when patients progress.
In a Significant Percentage of Patients, Neoadjuvant Therapy Yields Equivalent Survival, With Better Quality of Life and Lower Costs
Cytoreductive Surgery Is the Best Way to Affect Survival Outcomes